Dr. Bernstein is Chief of Gastroenterology at Mount Sinai Beth Israel and Clinical Associate Professor of Medicine. He currently serves as Medical Director of GI Services for the Mount Sinai Health System. Following graduation from the Mount Sinai School of Medicine, Dr. Bernstein completed post-graduate training at Mount Sinai Beth Israel where he served as an internal medicine resident, chief medical resident, and gastroenterology fellow. He has served in numerous leadership roles over the course of his over 30-year career at MSBI including Director of Endoscopy, Program Director for the MSBI GI Fellowship, and Chief Quality Officer for Beth Israel Ambulatory Services. In 2009, he founded Eastside Endoscopy, the first Manhattan-based joint venture single specialty endoscopy center between Beth Israel and a large group of community-based voluntary gastroenterologists. Dr. Bernstein has served as Medical Director of Eastside Endoscopy since its inception. As Medical Director of the Provider Partners of Mount Sinai IPA from 2015-2016, Dr. Bernstein was instrumental in the development and implementation of a clinical integration program for over 3,000 in-house and community-based physicians in the Mount Sinai Health System. As a national thought leader in endoscopic quality, Dr. Bernstein serves as a board member of GIQuIC, the largest national registry for GI quality data and was elected Chair of the registry’s new clinical measures committee. Additionally, Dr. Bernstein serves as Co-chair of the Colonoscopy Quality Committee, NYC Colonoscopy Quality Initiative Cancer Prevention and Control Program (C5). He has numerous peer reviewed publications and most recently co-authored “Guidance for resuming GI endoscopy and practice operations after the COVID-19 pandemic” appearing in the September 2021 issue of Gastrointestinal Endoscopy.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Gastroenterology
Hospital Affiliations
Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
Mount Sinai Queens
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai West
Show More
About Me
Dr. Bernstein is Chief of Gastroenterology at Mount Sinai Beth Israel and Clinical Associate Professor of Medicine. He currently serves as Medical Director of GI Services for the Mount Sinai Health System. Following graduation from the Mount Sinai School of Medicine, Dr. Bernstein completed post-graduate training at Mount Sinai Beth Israel where he served as an internal medicine resident, chief medical resident, and gastroenterology fellow. He has served in numerous leadership roles over the course of his over 30-year career at MSBI including Director of Endoscopy, Program Director for the MSBI GI Fellowship, and Chief Quality Officer for Beth Israel Ambulatory Services. In 2009, he founded Eastside Endoscopy, the first Manhattan-based joint venture single specialty endoscopy center between Beth Israel and a large group of community-based voluntary gastroenterologists. Dr. Bernstein has served as Medical Director of Eastside Endoscopy since its inception. As Medical Director of the Provider Partners of Mount Sinai IPA from 2015-2016, Dr. Bernstein was instrumental in the development and implementation of a clinical integration program for over 3,000 in-house and community-based physicians in the Mount Sinai Health System. As a national thought leader in endoscopic quality, Dr. Bernstein serves as a board member of GIQuIC, the largest national registry for GI quality data and was elected Chair of the registry’s new clinical measures committee. Additionally, Dr. Bernstein serves as Co-chair of the Colonoscopy Quality Committee, NYC Colonoscopy Quality Initiative Cancer Prevention and Control Program (C5). He has numerous peer reviewed publications and most recently co-authored “Guidance for resuming GI endoscopy and practice operations after the COVID-19 pandemic” appearing in the September 2021 issue of Gastrointestinal Endoscopy.
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Healthfirst Medicare Advantage insurance: Effective , Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.
10 Union Square East, 2H/J, New York, NY, 10003
1199 SEIU
AETNA - Commercial
AETNA - Medicare
Affinity Medicaid-Medicare-Essential Exchange
Amidacare Medicaid
CIGNA Healthcare
Centivo
Cigna - Medicare
Elderplan
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicaid
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Empire Blue Cross Blue Shield - HealthPlus Medicaid
Empire Blue Cross Blue Shield - Medicare
Fidelis Health Care
HealthFirst Medicaid
HealthFirst Medicare
Horizon NJ
Hotel Trades
Humana Medicare
Magnacare-Health Care
Medicare - NY
Metroplus
Multiplan PHCS
NY Medicaid
Oscar
Partners Health Plan
Senior Whole Health
United Health Care - Commercial
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
VNSNY Select Health Medicaid
VillageCareMax
WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.8 out of 5
Care Provider’s Concern
4.9 out of 5
Likelihood to Recommend Care Provider
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Bernstein during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Surgical Care Associates
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Eastside Endoscopy
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Show More
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Bernstein during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Surgical Care Associates
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Eastside Endoscopy
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.